IBD MEDICAL

IBD Medical specializes in single-use, non-conductive skin-adherent patches designed for securing cables, leads, or sensors to the skin. These patches are primarily used in continuous glucose monitoring systems to ensure sensors stay in place without conducting electricity. The company’s focus is on this specific category of Class I medical devices.

IBD Medical is based in the United States, which means its devices are subject to FDA regulatory requirements. Since the company’s products fall under Class I classification, they are generally considered low-risk, but they still must comply with FDA guidelines, including registration and UDI listing. The FDA’s Unique Device Identifier (UDI) database includes IBD Medical’s devices, ensuring traceability and transparency in the healthcare system.

Yes, IBD Medical’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry is critical because it provides standardized identification for medical devices, improving patient safety, tracking, and regulatory compliance. The UDI system helps healthcare providers, hospitals, and regulators quickly identify and verify devices, reducing errors and ensuring proper use.

IBD Medical’s devices are classified as Class I medical devices by the FDA. This classification is assigned based on risk level—Class I devices are generally considered the lowest risk and pose minimal potential harm to users. While this classification simplifies regulatory oversight, it does not exempt the company from adhering to manufacturing standards, labeling requirements, and other applicable regulations to ensure safety and effectiveness.